ATE388691T1 - Träger zur freisetzung von nanopartikeln - Google Patents

Träger zur freisetzung von nanopartikeln

Info

Publication number
ATE388691T1
ATE388691T1 AT02802543T AT02802543T ATE388691T1 AT E388691 T1 ATE388691 T1 AT E388691T1 AT 02802543 T AT02802543 T AT 02802543T AT 02802543 T AT02802543 T AT 02802543T AT E388691 T1 ATE388691 T1 AT E388691T1
Authority
AT
Austria
Prior art keywords
nanoparticle
delivery vehicle
active agent
nanoparticle delivery
target cell
Prior art date
Application number
AT02802543T
Other languages
English (en)
Inventor
Stefan Franzen
Daniel L Feldheim
Alexander G Tkachenko
Marisha L Godek
Joseph A Ryan
Miles F Anderson
Original Assignee
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina State filed Critical Univ North Carolina State
Application granted granted Critical
Publication of ATE388691T1 publication Critical patent/ATE388691T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
    • A61K49/0047—Green fluorescent protein [GFP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02802543T 2001-07-10 2002-07-10 Träger zur freisetzung von nanopartikeln ATE388691T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30423601P 2001-07-10 2001-07-10

Publications (1)

Publication Number Publication Date
ATE388691T1 true ATE388691T1 (de) 2008-03-15

Family

ID=23175645

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02802543T ATE388691T1 (de) 2001-07-10 2002-07-10 Träger zur freisetzung von nanopartikeln

Country Status (9)

Country Link
US (2) US7332586B2 (de)
EP (2) EP1450751B1 (de)
JP (1) JP2005511761A (de)
AT (1) ATE388691T1 (de)
AU (1) AU2002364927A1 (de)
CA (1) CA2453417A1 (de)
DE (1) DE60225589T2 (de)
ES (1) ES2304467T3 (de)
WO (1) WO2003051278A2 (de)

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7834349B2 (en) * 2000-03-29 2010-11-16 Georgia Tech Research Corporation Silicon based nanospheres and nanowires
WO2002045737A2 (en) * 2000-12-07 2002-06-13 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
AU2003228267A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
US8409618B2 (en) 2002-12-20 2013-04-02 Kimberly-Clark Worldwide, Inc. Odor-reducing quinone compounds
KR101012584B1 (ko) * 2002-12-20 2011-02-07 킴벌리-클라크 월드와이드, 인크. 알루미나 및 알루미나의 표면에 부착된 화합물을 함유하는입자들을 포함하는 조성물, 전달 시스템 및 제조 방법
US7666410B2 (en) 2002-12-20 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery system for functional compounds
US7582308B2 (en) 2002-12-23 2009-09-01 Kimberly-Clark Worldwide, Inc. Odor control composition
US7641912B1 (en) * 2003-01-13 2010-01-05 EnviroCare Corporation Antimicrobial coatings for treatment of surfaces in a building setting and method of applying same
US8282951B2 (en) 2003-01-13 2012-10-09 EnviroCare Corporation Antimicrobial coatings for treatment of surfaces in a building setting and method of applying same
WO2005002643A2 (en) * 2003-06-24 2005-01-13 Johns Hopkins University Method and products for delivering biological molecules to cells using multicomponent nanostructures
US7682631B2 (en) * 2003-10-01 2010-03-23 Clemson University Adhesin-specific nanoparticles and process for using same
US7438875B2 (en) 2003-10-16 2008-10-21 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified silica particles
US7794737B2 (en) 2003-10-16 2010-09-14 Kimberly-Clark Worldwide, Inc. Odor absorbing extrudates
US7413550B2 (en) 2003-10-16 2008-08-19 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US7488520B2 (en) 2003-10-16 2009-02-10 Kimberly-Clark Worldwide, Inc. High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
US7678367B2 (en) 2003-10-16 2010-03-16 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
US7754197B2 (en) 2003-10-16 2010-07-13 Kimberly-Clark Worldwide, Inc. Method for reducing odor using coordinated polydentate compounds
US7837663B2 (en) 2003-10-16 2010-11-23 Kimberly-Clark Worldwide, Inc. Odor controlling article including a visual indicating device for monitoring odor absorption
US7141518B2 (en) 2003-10-16 2006-11-28 Kimberly-Clark Worldwide, Inc. Durable charged particle coatings and materials
US7582485B2 (en) 2003-10-16 2009-09-01 Kimberly-Clark Worldride, Inc. Method and device for detecting ammonia odors and helicobacter pylori urease infection
US7879350B2 (en) 2003-10-16 2011-02-01 Kimberly-Clark Worldwide, Inc. Method for reducing odor using colloidal nanoparticles
WO2005082396A2 (en) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
EP1748796A4 (de) * 2004-03-05 2008-08-27 Univ Texas Vielschichtiges nanomedizin-abgabesystem und -verfahren
US7294340B2 (en) * 2004-03-30 2007-11-13 Chien-Min Sung Healthcare and cosmetic compositions containing nanodiamond
JP5398982B2 (ja) 2004-05-24 2014-01-29 ミダテック リミテッド Ｒｎａリガンドを含むナノ粒子
AU2005271781A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
WO2007013877A2 (en) * 2004-09-02 2007-02-01 The Regents Of The University Of California Signal peptide-semiconductor nanocrystal conjugates
WO2007018562A2 (en) * 2004-09-22 2007-02-15 Nanolab, Inc. Nanospearing for molecular transportation into cells
WO2006039369A1 (en) * 2004-09-29 2006-04-13 Alza Corporation Microparticles and nanoparticles containing a lipopolymer
EP1793863B1 (de) * 2004-10-01 2017-04-12 Midatech Ltd. Nanopartikel mit antigenen und adjuvanten, die t helferzellen aktivieren können
GB0426182D0 (en) * 2004-11-30 2004-12-29 Univ St Andrews Photoporation of cells
JP4736413B2 (ja) * 2004-12-14 2011-07-27 富士ゼロックス株式会社 生体分子保持物及び生体分子の保存方法
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
AU2006210416A1 (en) * 2005-02-04 2006-08-10 Auburn University Contact drug delivery system
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
US20060222595A1 (en) * 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
DE102005016873A1 (de) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
US20060246143A1 (en) * 2005-04-28 2006-11-02 Hilmi Ege Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles
DE602006012310D1 (de) * 2005-05-26 2010-04-01 Flamma Spa An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
DE102005033855B4 (de) * 2005-07-12 2009-04-02 Siemens Ag Nanopartikel und Verfahren zum Transportieren eines Nanopartikels
WO2007014348A2 (en) * 2005-07-29 2007-02-01 North Carolina University Photocrosslinking probes and uses of the same
US9248034B2 (en) * 2005-08-23 2016-02-02 Advanced Cardiovascular Systems, Inc. Controlled disintegrating implantable medical devices
US8240190B2 (en) * 2005-08-23 2012-08-14 Uwm Research Foundation, Inc. Ambient-temperature gas sensor
US8268405B2 (en) * 2005-08-23 2012-09-18 Uwm Research Foundation, Inc. Controlled decoration of carbon nanotubes with aerosol nanoparticles
WO2007092944A2 (en) * 2006-02-08 2007-08-16 Introgen Therapeutics, Inc. Compositions and methods involving gene therapy and proteasome modulation
WO2007127767A2 (en) * 2006-04-28 2007-11-08 Ludwig Institute For Cancer Research Quantification of enzyme activity by mass spectrometry
WO2008127414A2 (en) * 2006-11-08 2008-10-23 Northwestern University Colorimetric detection of metallic ions in aqueous media using functionlized nanoparticles
WO2008060575A2 (en) * 2006-11-13 2008-05-22 Auburn University Drug delivery system and method
WO2008073856A2 (en) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
EP2121987B1 (de) 2007-02-09 2012-06-13 Northwestern University Partikel zur erkennung intrazellulärer ziele
CA2679586A1 (en) * 2007-02-27 2008-10-23 Northwestern University Molecule attachment to nanoparticles
CN101678090B (zh) 2007-03-07 2012-04-11 乌第有限合伙公司 用于预防和治疗自身免疫病的组合物和方法
EP2160464B1 (de) 2007-05-30 2014-05-21 Northwestern University Nukleinsäure-funktionalisierte nanopartikel für therapeutische anwendungen
AU2014262264B2 (en) * 2007-05-30 2017-01-05 Northwestern University Nucleic Acid Functionalized Nanoparticles For Therapeutic Applications
US7807372B2 (en) * 2007-06-04 2010-10-05 Northwestern University Screening sequence selectivity of oligonucleotide-binding molecules using nanoparticle based colorimetric assay
EP2039254A1 (de) * 2007-09-14 2009-03-25 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Induzierbares Freigabemittel in Hybridform
WO2009038776A1 (en) * 2007-09-18 2009-03-26 Victor Manneh Therapeutic nanoconjugates
US10550415B2 (en) 2007-10-17 2020-02-04 Cornell Research Foundation, Inc. System for production of adenosine triphosphate
US9186317B2 (en) * 2007-11-26 2015-11-17 Stc.Unm Active nanoparticles and method of using
EP2288336B8 (de) 2008-04-25 2017-03-22 Northwestern University Für die veresterung mit cholesterol geeignete nanostrukturen
DE102008023228A1 (de) 2008-05-08 2009-11-19 Technische Universität Dresden Nanopartikel zur selektiven Gewebetherapie, Verfahren zu deren Herstellung und deren Verwendung in der Gewebetherapie
RU2444571C2 (ru) * 2008-05-28 2012-03-10 Учреждение Российской Академии наук Институт катализа им.Г.К.Борескова Сибирского отделения РАН (ИК СО РАН) Нанокомпозиты диоксида титана для инактивации вирусного генома внутри клеток, способ их получения
DE102008033175A1 (de) * 2008-07-15 2010-01-21 Merck Patent Gmbh Siliciumdioxid-Nanopartikel und deren Verwendung zur Vakzinierung
WO2010022321A1 (en) * 2008-08-21 2010-02-25 Georgia Tech Research Corporation Gas sensors, methods of preparation thereof, methods of selecting gas sensor materials, and methods of use of gas sensors
JP5753784B2 (ja) 2008-10-10 2015-07-22 ダラ・バイオサイエンシズ，インコーポレイテッド スピカマイシン誘導体を用いて疼痛を治療又は予防する方法
EP2365803B1 (de) 2008-11-24 2017-11-01 Northwestern University Polyvalente rna-nanoteilchen-zusammensetzungen
AU2010203474B2 (en) * 2009-01-08 2015-11-19 Northwestern University Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
KR101546673B1 (ko) * 2009-01-15 2015-08-25 삼성전자주식회사 전자 사진용 토너 및 그의 제조방법
US20110033940A1 (en) * 2009-01-30 2011-02-10 Northwestern University Click chemistry, molecular transport junctions, and colorimetric detection of copper
CN102449170A (zh) 2009-04-15 2012-05-09 西北大学 寡核苷酸功能化的纳米颗粒的递送
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
WO2011017297A2 (en) 2009-08-03 2011-02-10 The University Of North Carolina At Chapel Hill Biodegradable delivery system complexes for the delivery of bioactive compounds
US20110073412A1 (en) 2009-09-28 2011-03-31 Tlt-Babcock, Inc. Axial fan compact bearing viscous pump
CA2779099C (en) 2009-10-30 2021-08-10 Northwestern University Templated nanoconjugates
EP2496268A4 (de) * 2009-11-06 2013-06-19 Univ Chung Ang Ind Genabgabesysteme auf nanopartikelbasis
US8445228B2 (en) 2009-11-16 2013-05-21 Massachusetts Institute Of Technology Enhancement of in vitro translation by nanoparticle conjugates
CN102884204B (zh) * 2010-01-12 2015-03-25 新加坡科技研究局 利用纳米颗粒探针进行的核酸的序列选择性识别
AU2011207563B2 (en) 2010-01-19 2016-03-10 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
EP2547328B1 (de) * 2010-02-11 2017-06-07 Ecole Polytechnique Fédérale de Lausanne (EPFL) Ccr7-liganden-verabreichung und co-verabreichung in einer immuntherapie
US20130101512A1 (en) 2010-03-12 2013-04-25 Chad A. Mirkin Crosslinked polynucleotide structure
US8362207B2 (en) 2010-04-16 2013-01-29 Wake Forest University Health Sciences Multi-level specific targeting of cancer cells with IL-13
US9545421B2 (en) 2010-05-04 2017-01-17 General Electric Company Nucleic acid delivery vehicle and uses thereof
WO2012074588A2 (en) 2010-08-30 2012-06-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
US8632789B2 (en) 2010-11-01 2014-01-21 Syracuse University System and method for delivery of DNA-binding chemotherapy drugs using nanoparticles
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US9448231B2 (en) * 2011-02-28 2016-09-20 Ventana Medical Systems, Inc. Application of quantum dots for nuclear staining
US20120323112A1 (en) * 2011-06-17 2012-12-20 The Board Of Trustees Of The Leland Stanford Junior University Nanoparticles for accoustic imaging, methods of making, and methods of accoustic imaging
WO2013033802A1 (en) 2011-09-08 2013-03-14 Nanox Tecnologia S/A Antimicrobial compositions and uses thereof
WO2013036799A2 (en) 2011-09-09 2013-03-14 Fred Hutchinson Cancer Research Center Methods and compositions involving nkg2d inhibitors and cancer
AU2012305715A1 (en) 2011-09-11 2014-04-10 Aurasense, Llc Cellular uptake control systems
AU2012308302A1 (en) 2011-09-14 2014-03-20 Northwestern University Nanoconjugates able to cross the blood-brain barrier
US9051583B2 (en) 2011-12-19 2015-06-09 Northwestern University Modified silica shell particles, and methods of making and using the same
GB201204579D0 (en) * 2012-03-15 2012-05-02 Univ Nottingham Trent Coating metal oxide particles
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
WO2013166487A1 (en) 2012-05-04 2013-11-07 Yale University Highly penetrative nanocarriers for treatment of cns disease
GB201209517D0 (en) * 2012-05-29 2012-07-11 Univ Birmingham Nanoparticles
US20140017263A1 (en) 2012-06-28 2014-01-16 Clemson University Delivery Agents for Targeted Treatment of Elastin Degradation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
US9468681B2 (en) 2013-03-01 2016-10-18 California Institute Of Technology Targeted nanoparticles
WO2014185964A1 (en) 2013-05-14 2014-11-20 California Institute Of Technology Method of delivering therapeutics and imaging agents by nanoparticles that cross the blood brain barrier
WO2014197586A1 (en) 2013-06-04 2014-12-11 Virginia Commonwealth University Mda-9/syntenin promoter to image and treat metastatic cancer cells
EP3024936B1 (de) 2013-07-25 2019-09-04 Exicure, Inc. Sphärische nukleinsäurebasierte konstrukte als immunstimulatoren für prophylaktische und therapeutische verwendung
JP2016534094A (ja) 2013-07-25 2016-11-04 イグジキュア, インコーポレーテッドExicure, Inc. 免疫調節剤としての球状核酸に基づくコンストラクト
US10568898B2 (en) 2013-08-13 2020-02-25 Northwestern University Lipophilic nanoparticles for drug delivery
US20160201031A1 (en) * 2013-08-21 2016-07-14 The Regents Of The University Of California Composition and methods for culturing cells
AU2014343379B2 (en) 2013-11-04 2019-02-14 Uti Limited Partnership Methods and compositions for sustained immunotherapy
US10301622B2 (en) 2013-11-04 2019-05-28 Northwestern University Quantification and spatio-temporal tracking of a target using a spherical nucleic acid (SNA)
WO2015070210A1 (en) 2013-11-11 2015-05-14 Wake Forest University Health Sciences Epha3 and multi-valent targeting of tumors
US10182988B2 (en) 2013-12-03 2019-01-22 Northwestern University Liposomal particles, methods of making same and uses thereof
TR201908550T4 (tr) 2014-06-04 2019-07-22 Exicure Inc Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi.
WO2016028940A1 (en) 2014-08-19 2016-02-25 Northwestern University Protein/oligonucleotide core-shell nanoparticle therapeutics
CR20170181A (es) 2014-10-06 2017-05-31 Exicure Inc Compuestos anti-tnf
CN104324380B (zh) * 2014-10-17 2017-08-01 华东理工大学 一种纳米药物载体及其制备方法和应用
US11213593B2 (en) 2014-11-21 2022-01-04 Northwestern University Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
CA2973702A1 (en) 2015-01-14 2016-07-21 Exicure, Inc. Nucleic acid nanostructures with core motifs
US10078092B2 (en) 2015-03-18 2018-09-18 Northwestern University Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
EP3291832B1 (de) 2015-05-06 2025-09-03 UTI Limited Partnership Nanopartikelzusammensetzungen zur verzögerten therapie
ES2882255T3 (es) 2015-07-01 2021-12-01 California Inst Of Techn Sistemas de administración basados en polímeros de ácido múcico catiónicos
DE102016000865A1 (de) * 2016-01-28 2017-08-03 Friz Biochem Gesellschaft Für Bioanalytik Mbh Funktionalisierte metallische Nanopartikel
US10188749B2 (en) 2016-04-14 2019-01-29 Fred Hutchinson Cancer Research Center Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
EP3452598A4 (de) 2016-05-06 2020-04-29 Exicure, Inc. Konstrukte aus liposomaler sphärischer nukleinsäure (sna) mit antisense-oligonukleotiden (aso) zum spezifischen knockdown von interleukin-17-rezeptor-mrna
ITUA20163432A1 (it) * 2016-05-13 2017-11-13 Fondazione St Italiano Tecnologia Processo per la preparazione di nanoparticelle cave con un core metallico
WO2017210666A2 (en) * 2016-06-03 2017-12-07 Stemgenics, Inc. Functionalized nanoparticles for the intracellular delivery of biologically active molecules and methods for their manufacture and use
WO2017216775A2 (en) 2016-06-16 2017-12-21 The Regents Of The University Of California Identification of factor that promotes human hsc self-renewal
WO2018039629A2 (en) 2016-08-25 2018-03-01 Northwestern University Micellar spherical nucleic acids from thermoresponsive, traceless templates
CN110121336A (zh) 2017-01-05 2019-08-13 弗莱德哈钦森癌症研究中心 改善疫苗功效的系统和方法
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)
US10543231B2 (en) 2017-05-19 2020-01-28 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
MX2020000387A (es) 2017-07-13 2020-08-17 Univ Northwestern Método general y directo para preparar nanopartículas de estructura organometálica funcionalizadas con oligonucleotidos.
CA3083748A1 (en) 2017-11-29 2019-06-06 Uti Limited Partnership Methods of treating autoimmune disease
KR20250099256A (ko) 2018-01-18 2025-07-01 프레드 허친슨 캔서 센터 세포 활성화 상태를 조절함으로써 생체내 면역 세포의 염증 상태의 변경
WO2019241327A1 (en) 2018-06-13 2019-12-19 California Institute Of Technology Nanoparticles for crossing the blood brain barrier and methods of treatment using the same
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
CN113614535B (zh) 2018-10-31 2024-08-16 亚利桑那大学评议会 用于辐射诱导的肺损伤的生物标志物和使用方法
US20220175956A1 (en) 2019-03-06 2022-06-09 Northwestern University Hairpin-like oligonucleotide-conjugated spherical nucleic acid
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids
CN111110855B (zh) * 2019-12-26 2023-06-23 深圳百纳心致生命科学有限公司 一种利用红细胞制备的靶向性的囊泡药物
KR20230088732A (ko) 2020-09-29 2023-06-20 옥스포드 유니버시티 이노베이션 리미티드 뇌졸중 치료
CN113209046B (zh) * 2021-05-08 2022-09-09 中国人民解放军陆军军医大学 一种CoSe@BSA纳米粒子药物组合物及其制备方法和应用
US20240384246A1 (en) * 2021-05-27 2024-11-21 Astrazeneca Ab Ca s9 effector proteins with enhanced stability
CN119372734B (zh) * 2024-12-23 2025-04-08 浙江大学 一种利用级联电交换技术制备高熵合金的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (de) 1981-11-12 1983-11-16 Ulf SCHRÖDER Verfahren zur herstellung von magnetisch beeinflussbaren nanopartikeln für intravaskulare anwendung
GB8601100D0 (en) 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
US5178882A (en) 1990-06-22 1993-01-12 The Regents Of The University Of California Viral decoy vaccine
US5460830A (en) 1990-06-22 1995-10-24 The Regents Of The University Of California Biochemically active agents for chemical catalysis and cell receptor activation
US5462751A (en) * 1990-06-22 1995-10-31 The Regeants Of The University Of California Biological and pharmaceutical agents having a nanomeric biodegradable core
US5460831A (en) 1990-06-22 1995-10-24 The Regents Of The University Of California Targeted transfection nanoparticles
US5219577A (en) 1990-06-22 1993-06-15 The Regents Of The University Of California Biologically active composition having a nanocrystalline core
US5521291A (en) * 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
US6033884A (en) 1992-03-20 2000-03-07 Baylor College Of Medicine Nucleic acid transporter systems and methods of use
MX9401351A (es) * 1993-02-22 1994-08-31 Alza Corp Composiciones para suministro oral para agentes activos.
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
CN1064777C (zh) 1993-06-24 2001-04-18 卡耐基米龙大学 金属、合金或金属碳化物的纳米颗粒及其制备方法
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2739292B1 (fr) 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
WO1998056363A1 (en) 1997-06-13 1998-12-17 The Johns Hopkins University Knobby nanospheres
US6106798A (en) 1997-07-21 2000-08-22 Nanogram Corporation Vanadium oxide nanoparticles
AU9570898A (en) * 1997-09-18 1999-04-05 Gene Therapy Systems, Inc. Chemical modification of dna using peptide nucleic acid conjugates
WO2001027154A2 (en) * 1999-09-27 2001-04-19 Mahony Daniel J O Membrane translocating peptide drug delivery system
US7241742B2 (en) 2000-10-31 2007-07-10 Mgi Pharma Biologics, Inc. CYP1B1 nucleic acids and methods of use

Also Published As

Publication number Publication date
EP1990040A1 (de) 2008-11-12
US20030147966A1 (en) 2003-08-07
JP2005511761A (ja) 2005-04-28
WO2003051278A2 (en) 2003-06-26
ES2304467T3 (es) 2008-10-16
EP1450751B1 (de) 2008-03-12
AU2002364927A1 (en) 2003-06-30
DE60225589T2 (de) 2009-04-23
WO2003051278A3 (en) 2004-07-01
EP1450751A4 (de) 2006-03-22
US20080199529A1 (en) 2008-08-21
CA2453417A1 (en) 2003-06-26
EP1450751A2 (de) 2004-09-01
DE60225589D1 (de) 2008-04-24
US7332586B2 (en) 2008-02-19

Similar Documents

Publication Publication Date Title
DE60225589D1 (de) Träger zur freisetzung von nanopartikeln
Noh et al. A biodegradable magnetic microrobot based on gelatin methacrylate for precise delivery of stem cells with mass production capability
Kane et al. Nanobiotechnology: protein‐nanomaterial interactions
Xia et al. Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation
Neugart et al. Dynamics of diamond nanoparticles in solution and cells
Budhathoki-Uprety et al. A carbon nanotube optical sensor reports nuclear entry via a noncanonical pathway
BR9805335A (pt) Dispositivo e processo para fornecer um sinal, sistema de suspensão ativa de veículo e dispositivo para controlar a suspensão de um veículo.
Homaei et al. Immobilized papain on gold nanorods as heterogeneous biocatalysts
DE60026544D1 (de) Verwendung von einfachen aminosäuren zur herstellung von porösen partikeln
CA2267973A1 (en) Hydrophilic microparticles and methods to prepare same
AU3649397A (en) Precise efficacy assay methods for active agents including chemotherapeutic agents
WO2005032511A3 (en) Nanoparticulate therapeutic biologically active agents
Lin et al. Hyperglycemia targeting nanomotors for accelerated healing of diabetic wounds by efficient microenvironment remodeling
ATE249209T1 (de) Arzneistoffträgerpartikel für die gewebespezifische arzneistoffapplikation
CY1106387T1 (el) Τμηματοποιημενα μορια μεταφορεα αντιγονου (ματ-μορια) για τη διαμορφωση ανοσοαποκρισεων, αντιστοιχα δομηματα, μεθοδοι και χρησεις
ATE161174T1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
Reibetanz et al. Flow cytometry of HEK 293T cells interacting with polyelectrolyte multilayer capsules containing fluorescein-labeled poly (acrylic acid) as a pH sensor
Chen et al. Enhanced stability and bioconjugation of photo-cross-linked polystyrene-shell, Au-core nanoparticles
Gao et al. Nanozymes: biomedical applications of enzymatic Fe3O4 nanoparticles from in vitro to in vivo
WO2003050260A3 (en) Streptavidin expressed gene fusions and methods of use thereof
Patel et al. Probing stem cell behavior using nanoparticle‐based approaches
Terracciano et al. In vivo toxicity assessment of hybrid diatomite nanovectors using hydra vulgaris as a model system
Perikala et al. One-step colloidal synthesis of non-toxic electroactive carbon dots with a better threshold cytotoxicity and cytocompatibility
Nagasaki PEG-b-polyamine stabilized bionanoparticles for nanodiagnostics and nanotherapy
Hiller et al. Protamine assembled in multilayers on colloidal particles can be exchanged and released

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties